Table 1.

Demographic and Clinical Characteristics of Study Cohort

Variables	Focal thyroid uptake, N  = 14 patients	Diffuse thyroid uptake, N = 12 patients	Patients without diffuse or focal uptake, N = 211 patients
Age
Average ± SD, years	54.9 ± 11.1	56.7 ± 11.4	52.7 ± 14.0
Range, years	72–39	34–72	15–83
Sex
Female	9/14 (64.3%)	8/12 (66.7%)	112/211 (53.1%)
Race/ethnicity
White non-Hispanic	10/14 (71.4%)	12/12 (100%)	175/211 (82.9%)
Hispanic	3/14 (21.4%)	0	13/211 (6.2%)
Black	1/14 (7.1%)	0	17/211 (8.1%)
Asian	0/14 (0%)	0	6/211 (2.8%)
Diagnosis
Sporadic NET	10/14 (71.4%)	6/12 (50.0%)	137/211 (64.9%)
MEN1	1/14 (7.1%)	3/12 (25.0%)	39/211 (18.5%)
VHL	1/14 (7.1%)	1/12 (8.3%)	26/211 (12.3%)
Other	2/14 (14.2%)	2/12 (16.7%)	9/211 (4.3%)
Total	14	12	211

NET, neuroendocrine tumor; MEN1, multiple endocrine neoplasia type 1; VHL, von Hippel–Lindau.